おかもと よしあき
岡本 禎晃
OKAMOTO Yoshiaki
看護学部看護学科 教授
大学院看護学研究科 教授
Email y-okamoto
学 位
博士（薬学）
最終学歴
大阪薬科大学
主な職歴
大阪大学医学部附属病院 文部科学技官（薬剤師）
大阪大学大学院薬学研究科 講師
市立芦屋病院 薬剤部長
市立敦賀病院 緩和ケアチーム
大阪大学大学院薬学研究科 講師
市立芦屋病院 薬剤部長
市立敦賀病院 緩和ケアチーム
学会活動 （所属学会・ 役職）
日本緩和医療学会：利益相反員会委員 会則検討委員会 渉外委員会委員 学術大会組織委員
日本緩和医療薬学会：理事 総務委員会委員長
日本ホスピス緩和ケア協会：多職種教育プログラム作成WG
日本サイコオンコロジー学会：代議員 多職種協働委員会、ガイドライン策定委員会せん妄小委員会 広報・普及啓発委員会委員 薬剤師教育委員会委員長
日本がんサポーティブケア学会：代議員 専門認定制度委員会委員 JASCC教育研究開発ワーキンググループ委員 会員委員会委員
日本病院薬剤師会：特別会員
北陸緩和医療研究会 世話人
ヨーロッパ緩和ケア学会（European Association for Palliative Care: EAPC）
日本緩和医療薬学会：理事 総務委員会委員長
日本ホスピス緩和ケア協会：多職種教育プログラム作成WG
日本サイコオンコロジー学会：代議員 多職種協働委員会、ガイドライン策定委員会せん妄小委員会 広報・普及啓発委員会委員 薬剤師教育委員会委員長
日本がんサポーティブケア学会：代議員 専門認定制度委員会委員 JASCC教育研究開発ワーキンググループ委員 会員委員会委員
日本病院薬剤師会：特別会員
北陸緩和医療研究会 世話人
ヨーロッパ緩和ケア学会（European Association for Palliative Care: EAPC）
学 術 賞
15th World Congress of the European Association for Palliative Care ポスター賞
2020年 日本サイコオンコロジー学会 教育功労賞
2022年 薬事功労賞（知事賞）
2022年 薬事協会長表彰
2024年 日本病院薬剤師会 病院薬学賞
2020年 日本サイコオンコロジー学会 教育功労賞
2022年 薬事功労賞（知事賞）
2022年 薬事協会長表彰
2024年 日本病院薬剤師会 病院薬学賞
専門分野
緩和医療
キーワード
緩和医療、疼痛、薬物治療 補完代替医療
研究課題
緩和薬物療法、予後予測
主な著書・論文・学会発表等
主な原著論文
1. Kazuyuki Niki, Satomi Egashira, Yoshiaki Okamoto A real-time virtual outing using virtual reality for a hospitalized terminal cancer patient who has difficulty going out: A case report Frontiers in Virtual Reality 5 2024
2. Kazuyuki Niki, Yoshiaki Okamoto, Maki Yasui, Takahito Omae, Makie Kohno, and Yoshinobu Matsuda. Is a Combination of Six Clinical Tests Useful as a Measure to Predict Short-Term Prognosis in Terminal Cancer Patients? A Prospective Observational Study in a Japanese Palliative Care Unit. Palliat Med Rep. 2024 Oct 9;5(1):430-437. doi: 10.1089/pmr.2024.0026. eCollection 2024.
3. Niki K, Egashira S, Okamoto Y. A real-time virtual outing using virtual reality for a hospitalized terminal cancer patient who has difficulty going out: a case report. Case Report. 09 May 2024. DOI 10.3389/frvir.2024.1269707
4. Yoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, Takatoshi Hirayama, Yusuke Kanno, Yuichi Kitaura, Shuji Inada, Koji Sugano, Masafumi Yoshimura, Saki Harashima, Saho Wada, Takaaki Hasegawa, Yoshiaki Okamoto, Chikako Dotani, Mari Takeuchi, Jun Kako, Ryoichi Sadahiro, Yasuhiro Kishi, Megumi Uchida, Asao Ogawa, Masatoshi Inagaki, Toru Okuyama. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2023 Aug 30;53(9):808-822. doi: 10.1093/jjco/hyad042.
5. Nakagawa S, Tsuji K, Ishida S, Tsunoda N, Okamoto Y. Comparison of the Effects of Diuretics on Pedal Edema in Patients with Cancer. Palliat Med Rep. 2022 Aug 18;3(1):162-168. doi: 10.1089/pmr.2022.0017. eCollection 2022 PMID: 36059912
6. Takemura M, Niki K, Okamoto Y, Matsuda Y, Omae T, Takagi T, Ueda M. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi: 10.1248/bpb.b21-00212.
7. Tanaka I, Okamoto Y, Takahashi Y, Asada S, Numata C. Are Corticosteroids Useful for End-stage Cancer Patients? A Retrospective Chart Review in the Palliative Care Unit. Jpn. J. Pharm Palliet Care Sci, VOL.14 No.2 June 2021
8. Takemura M, Niki K, Okamoto Y, Matsuda Y, Ueda M, Uejima E. Terminal Cancer Patients Can Be Determined Earlier than 7 Days: A Preliminary Retrospective Study. JMA J. 2020 Jul 15;3(3):258-264. doi: 10.31662/jmaj.2019-0039. Epub 2020 Jul 7.
9. Niki K, Okamoto Y, Ueda M. Response to Wang et al., Virtual Reality as a Bridge in Palliative Care during COVID-19. J Palliat Med. 2020 Jul;23(7):892-894. doi: 10.1089/jpm.2020.0261. Epub 2020 May 11.
10. Hashimoto M, Aogaki K, Numata C, Moriwaki K, Matsuda Y, Ishii R, Tanaka I, Okamoto Y. Factors influencing the prescribed dose of opioid analgesics in cancer patients. J Opioid Manag. 2020 Jul/Aug;16(4):247-252. doi: 10.5055/jom.2020.0578.
11. Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H, Okamoto Y, Takeuchi M, Fujisawa D, Kako J, Sasaki C, Kishi Y, Akizuki N, Inagaki M, Uchitomi Y, Matsushima E, Okuyama T. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2020 May 5;50(5):586-593. doi: 10.1093/jjco/hyaa003.
12. Niki K, Okamoto Y, Maeda I, Ueda M. Responses to Kako et al. (DOI: 10.1089/jpm.2019.0072) and Niki et al. (DOI: 10.1089/jpm.2018.0233): A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Dec;22(12):1490. doi: 10.1089/jpm.2019.0487. No abstract available.
13. Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jun;22(6):685-690. doi: 10.1089/jpm.2018.0422. Epub 2019 Jan 14.
14. Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jun;22(6):702-707. doi: 10.1089/jpm.2018.0527. Epub 2019 Jan 24.
15. Adachi T, Sunohara M, Enomoto K, Sasaki K, Sakaue G, Fujita Y, Mizuno Y, Okamoto Y, Miki K, Yukioka M, Nitta K, Iwashita N, Kitagawa H, Shibata M, Sasaki J, Jensen M, Fukui S. Japanese cross-cultural validation study of the Pain Stage of Change Questionnaire. PAIN Reports, Volume 4 - Issue 2 - p e711
16. Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jan 24. doi: 10.1089/jpm.2018.0527. [Epub ahead of print]
17. Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jan 14. doi: 10.1089/jpm.2018.0422. [Epub ahead of print]
18. Okamoto Y, Morita T, Tsuneto S, Aoyama M, Kizawa Y, Shima Y, Miyashita M*. Bereaved Family Members' Perceptions of the Distressing Symptoms of Terminal Patients with Cancer. Am J Hosp Palliat Care. 2018 Jul;35(7):972-977. doi: 10.1177/1049909118765409.
19. Niki K, Okamoto Y, Nakajima S, Uejima E*. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would appear to patients administered under 45 mg/day opioid (oral morphine equivalents). Pharmazie 2018 73(3):161-164. doi: 10.1691/ph.2018.7878.
20. Miyashita M, Aoyama M, Yoshida S, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Nakahata M*. The distress and benefit to bereaved family members of participating in a post-bereavement survey. Jpn J Clin Oncol. 2018 Feb 1;48(2):135-143. doi: 10.1093/jjco/hyx177.
21. Niki K, Okamoto Y, Tabata Y, Tsugane M, Murata T, Mizuki M, Matsumura Y, Takagi T, Uejima E*. A New Approach for Determining Short-Term, Objective Prognostic Predictive Methods for Terminal Cancer Patients Based on the Change Point of Laboratory Test Values. J Palliat Med. 2017 Nov 17. 529-532. doi: 10.1089/jpm.2017.0233.
22. Okamoto Y, Tsuneto S, Morita T, Takagi T, Shimizu M, Miyashita M, Uejima E, Shima Y*. Desirable Information of Opioids for Families of Patients with Terminal Cancer: The Bereaved Family Members' Experiences and Recommendations. Am J Hosp Palliat Care. 2017 Apr;34(3):248-253. doi: 10.1177/1049909115626701.
23. Miyashita M, Aoyama M, Nakahata M, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Yoshida S, Sato K, Hirai K, Morita T*. Development the Care Evaluation Scale Version 2.0: a modified version of a measure for bereaved family members to evaluate the structure and process of palliative care for cancer patient. BMC Palliat Care. 2017 Jan 23;16(1):8.
24. Tanimukai H, Tsujimoto H, Matsuda Y, Watanabe M, Tsujio I, Maeda I, Takei K, Nakajima S, Taira T, Tokuyama M, Kai T, Okamoto Y, Goya S, and Kashiwagi Y. Novel Therapeutic Strategies for Delirium in Patients With Cancer:Preliminary Study. Am J Hosp Palliat Care. 2016 Jun;33(5):456-62. doi: 10.1177/1049909114565019.
25. Akashi N, Okamoto Y, Takei K, Nakagawa S, Tanaka I, Mita A, Shindo K，Can a novel diuretic Tolvaptan improve the edema of advanced cancer patients? . PALLIATIVE MEDICINE Vol.28 No.6, 888, 2014 Impact Factor:3.75
26. Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can Gradual Dose Titration of Ketamine for Management of Neuropathic Pain Prevent Psychotomimetic Effects in Patients with Advanced Cancer? Am J Hosp Palliat Care. 2013 Aug;30(5):450-4. doi: 10.1177/1049909112454325.
27. Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S．An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
28. Nagase M, Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Okishiro N, Ohno Y, Tsugane M, Takagi T, Uejima E．A Retrospective Chart Review of Terminal Patients with Cancer with Agitation and Their Risk Factors. J Palliat Med. 15(11): 2012
29. Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S. An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
30. Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can milnacipran used for neuropathic pain in patients with advanced cancer cause neuromuscular and somatosensory disorders? J Palliat Med. 2011 Apr;14(4):403-5. doi: 10.1089/jpm.2010.0485.
1. Kazuyuki Niki, Satomi Egashira, Yoshiaki Okamoto A real-time virtual outing using virtual reality for a hospitalized terminal cancer patient who has difficulty going out: A case report Frontiers in Virtual Reality 5 2024
2. Kazuyuki Niki, Yoshiaki Okamoto, Maki Yasui, Takahito Omae, Makie Kohno, and Yoshinobu Matsuda. Is a Combination of Six Clinical Tests Useful as a Measure to Predict Short-Term Prognosis in Terminal Cancer Patients? A Prospective Observational Study in a Japanese Palliative Care Unit. Palliat Med Rep. 2024 Oct 9;5(1):430-437. doi: 10.1089/pmr.2024.0026. eCollection 2024.
3. Niki K, Egashira S, Okamoto Y. A real-time virtual outing using virtual reality for a hospitalized terminal cancer patient who has difficulty going out: a case report. Case Report. 09 May 2024. DOI 10.3389/frvir.2024.1269707
4. Yoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, Takatoshi Hirayama, Yusuke Kanno, Yuichi Kitaura, Shuji Inada, Koji Sugano, Masafumi Yoshimura, Saki Harashima, Saho Wada, Takaaki Hasegawa, Yoshiaki Okamoto, Chikako Dotani, Mari Takeuchi, Jun Kako, Ryoichi Sadahiro, Yasuhiro Kishi, Megumi Uchida, Asao Ogawa, Masatoshi Inagaki, Toru Okuyama. A revision of JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2023 Aug 30;53(9):808-822. doi: 10.1093/jjco/hyad042.
5. Nakagawa S, Tsuji K, Ishida S, Tsunoda N, Okamoto Y. Comparison of the Effects of Diuretics on Pedal Edema in Patients with Cancer. Palliat Med Rep. 2022 Aug 18;3(1):162-168. doi: 10.1089/pmr.2022.0017. eCollection 2022 PMID: 36059912
6. Takemura M, Niki K, Okamoto Y, Matsuda Y, Omae T, Takagi T, Ueda M. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi: 10.1248/bpb.b21-00212.
7. Tanaka I, Okamoto Y, Takahashi Y, Asada S, Numata C. Are Corticosteroids Useful for End-stage Cancer Patients? A Retrospective Chart Review in the Palliative Care Unit. Jpn. J. Pharm Palliet Care Sci, VOL.14 No.2 June 2021
8. Takemura M, Niki K, Okamoto Y, Matsuda Y, Ueda M, Uejima E. Terminal Cancer Patients Can Be Determined Earlier than 7 Days: A Preliminary Retrospective Study. JMA J. 2020 Jul 15;3(3):258-264. doi: 10.31662/jmaj.2019-0039. Epub 2020 Jul 7.
9. Niki K, Okamoto Y, Ueda M. Response to Wang et al., Virtual Reality as a Bridge in Palliative Care during COVID-19. J Palliat Med. 2020 Jul;23(7):892-894. doi: 10.1089/jpm.2020.0261. Epub 2020 May 11.
10. Hashimoto M, Aogaki K, Numata C, Moriwaki K, Matsuda Y, Ishii R, Tanaka I, Okamoto Y. Factors influencing the prescribed dose of opioid analgesics in cancer patients. J Opioid Manag. 2020 Jul/Aug;16(4):247-252. doi: 10.5055/jom.2020.0578.
11. Matsuda Y, Tanimukai H, Inoue S, Inada S, Sugano K, Hasuo H, Yoshimura M, Wada S, Dotani C, Adachi H, Okamoto Y, Takeuchi M, Fujisawa D, Kako J, Sasaki C, Kishi Y, Akizuki N, Inagaki M, Uchitomi Y, Matsushima E, Okuyama T. JPOS/JASCC clinical guidelines for delirium in adult cancer patients: a summary of recommendation statements. Jpn J Clin Oncol. 2020 May 5;50(5):586-593. doi: 10.1093/jjco/hyaa003.
12. Niki K, Okamoto Y, Maeda I, Ueda M. Responses to Kako et al. (DOI: 10.1089/jpm.2019.0072) and Niki et al. (DOI: 10.1089/jpm.2018.0233): A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Dec;22(12):1490. doi: 10.1089/jpm.2019.0487. No abstract available.
13. Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jun;22(6):685-690. doi: 10.1089/jpm.2018.0422. Epub 2019 Jan 14.
14. Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jun;22(6):702-707. doi: 10.1089/jpm.2018.0527. Epub 2019 Jan 24.
15. Adachi T, Sunohara M, Enomoto K, Sasaki K, Sakaue G, Fujita Y, Mizuno Y, Okamoto Y, Miki K, Yukioka M, Nitta K, Iwashita N, Kitagawa H, Shibata M, Sasaki J, Jensen M, Fukui S. Japanese cross-cultural validation study of the Pain Stage of Change Questionnaire. PAIN Reports, Volume 4 - Issue 2 - p e711
16. Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective, Multicenter Study. J Palliat Med. 2019 Jan 24. doi: 10.1089/jpm.2018.0527. [Epub ahead of print]
17. Niki K, Okamoto Y, Matano Y, Ishii R, Matsuda Y, Takagi T, Uejima E. Validation of a Short-Term, Objective, Prognostic Predictive Method for Terminal Cancer Patients in a Palliative Care Unit Using a Combination of Six Laboratory Test Items. J Palliat Med. 2019 Jan 14. doi: 10.1089/jpm.2018.0422. [Epub ahead of print]
18. Okamoto Y, Morita T, Tsuneto S, Aoyama M, Kizawa Y, Shima Y, Miyashita M*. Bereaved Family Members' Perceptions of the Distressing Symptoms of Terminal Patients with Cancer. Am J Hosp Palliat Care. 2018 Jul;35(7):972-977. doi: 10.1177/1049909118765409.
19. Niki K, Okamoto Y, Nakajima S, Uejima E*. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would appear to patients administered under 45 mg/day opioid (oral morphine equivalents). Pharmazie 2018 73(3):161-164. doi: 10.1691/ph.2018.7878.
20. Miyashita M, Aoyama M, Yoshida S, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Nakahata M*. The distress and benefit to bereaved family members of participating in a post-bereavement survey. Jpn J Clin Oncol. 2018 Feb 1;48(2):135-143. doi: 10.1093/jjco/hyx177.
21. Niki K, Okamoto Y, Tabata Y, Tsugane M, Murata T, Mizuki M, Matsumura Y, Takagi T, Uejima E*. A New Approach for Determining Short-Term, Objective Prognostic Predictive Methods for Terminal Cancer Patients Based on the Change Point of Laboratory Test Values. J Palliat Med. 2017 Nov 17. 529-532. doi: 10.1089/jpm.2017.0233.
22. Okamoto Y, Tsuneto S, Morita T, Takagi T, Shimizu M, Miyashita M, Uejima E, Shima Y*. Desirable Information of Opioids for Families of Patients with Terminal Cancer: The Bereaved Family Members' Experiences and Recommendations. Am J Hosp Palliat Care. 2017 Apr;34(3):248-253. doi: 10.1177/1049909115626701.
23. Miyashita M, Aoyama M, Nakahata M, Yamada Y, Abe M, Yanagihara K, Shirado A, Shutoh M, Okamoto Y, Hamano J, Miyamoto A, Yoshida S, Sato K, Hirai K, Morita T*. Development the Care Evaluation Scale Version 2.0: a modified version of a measure for bereaved family members to evaluate the structure and process of palliative care for cancer patient. BMC Palliat Care. 2017 Jan 23;16(1):8.
24. Tanimukai H, Tsujimoto H, Matsuda Y, Watanabe M, Tsujio I, Maeda I, Takei K, Nakajima S, Taira T, Tokuyama M, Kai T, Okamoto Y, Goya S, and Kashiwagi Y. Novel Therapeutic Strategies for Delirium in Patients With Cancer:Preliminary Study. Am J Hosp Palliat Care. 2016 Jun;33(5):456-62. doi: 10.1177/1049909114565019.
25. Akashi N, Okamoto Y, Takei K, Nakagawa S, Tanaka I, Mita A, Shindo K，Can a novel diuretic Tolvaptan improve the edema of advanced cancer patients? . PALLIATIVE MEDICINE Vol.28 No.6, 888, 2014 Impact Factor:3.75
26. Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can Gradual Dose Titration of Ketamine for Management of Neuropathic Pain Prevent Psychotomimetic Effects in Patients with Advanced Cancer? Am J Hosp Palliat Care. 2013 Aug;30(5):450-4. doi: 10.1177/1049909112454325.
27. Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S．An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
28. Nagase M, Okamoto Y, Tsuneto S, Tanimukai H, Matsuda Y, Okishiro N, Ohno Y, Tsugane M, Takagi T, Uejima E．A Retrospective Chart Review of Terminal Patients with Cancer with Agitation and Their Risk Factors. J Palliat Med. 15(11): 2012
29. Tanimukai H, Murai T, Okazaki N, Matsuda Y, Okamoto Y, Kabeshita Y, Ohno Y, Tsuneto S. An Observational Study of Insomnia and Nightmare Treated With Trazodone in Patients With Advanced Cancer. Am J Hosp Palliat Care. 2013 Jun;30(4):359-62. doi: 10.1177/1049909112452334.
30. Nakagawa S, Okamoto Y, Tsuneto S, Tanimukai H, Goya S, Matsuda Y, Ohno Y, Tsugane M, Uejima E. Can milnacipran used for neuropathic pain in patients with advanced cancer cause neuromuscular and somatosensory disorders? J Palliat Med. 2011 Apr;14(4):403-5. doi: 10.1089/jpm.2010.0485.
31. Yoshiaki Okamoto 1, Satoru Tsuneto, Mamiko Tsugane, Tatsuya Takagi, Etsuko Uejima. A retrospective chart review of opioid-induced nausea and somnolence on commencement for cancer pain treatment. J Opioid Manag. 2010 Nov-Dec;6(6):431-4. doi: 10.5055/jom.2010.0041.
32. Yoshiaki Okamoto 1, Keiko Tazumi, Yasuaki Sanada, Mamiko Tsugane, Etsuko Uejima. Light-induced deterioration test of carboplatin under clinical settings. Yakugaku Zasshi. 2010 Oct;130(10):1369-74. doi: 10.1248/yakushi.130.1369.
33. Sari Nakagawa , Yoshie Toya, Yoshiaki Okamoto, Satoru Tsuneto, Sho Goya, Hitoshi Tanimukai, Yoichi Matsuda, Yumiko Ohno, Hiroshi Eto, Mamiko Tsugane, Tatsuya Takagi, Etsuko Uejima. Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives? J Palliat Med. 2010 May;13(5):535-40. doi: 10.1089/jpm.2009.0336.
34. Yoshiaki Okamoto , Satoru Tsuneto, Yoichi Matsuda, Takaya Inoue, Hitoshi Tanimukai, Keiko Tazumi, Yumiko Ono, Nobuo Kurokawa, Etsuko Uejima. A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. J Pain Symptom Manage. 2007 Aug;34(2):217-22. doi: 10.1016/j.jpainsymman.2006.10.020. Epub 2007 Jun 4.
最近の著書
１．荒尾 晴恵，岡本 禎晃 がん緩和ケア薬 必携ガイドブック 南江堂 2024年3月
２．谷向 仁，岡本 禎晃 その精神症状どうします？初めの処方・次の処方 南江堂 2023年5月
３．細谷 美紀，里見 絵理子，岡本 禎晃 がん疼痛治療薬まるわりBOOK第2版 照林社 2023年9月
４．岡本 禎晃 緩和医療薬学 改訂第2版 南江堂 2023年4月
５．岡本 禎晃（分担執筆）．がん支持医療テキストブック サポーティブケアとサバイバーシップ 金原出版 2022年10月
６．岡本 禎晃（分担執筆）．臨床腫瘍薬学 第2版 じほう 2022年9月
７．岡本 禎晃（分担執筆）．終末期ケア上級専門士 公式テキスト
８．岡本 禎晃（分担執筆）．言語聴覚士のためのパーキンソン病のリハビリテーションガイド 協同医書出版社 2019年7月
９．岡本 禎晃，荒井 幸子編集．がん緩和ケアの薬の使い方 じほう 2019年6月
１０．恒藤 暁 岡本 禎晃．緩和ケアエッセンシャルドラッグ第4版 医学書院 2019年3月
32. Yoshiaki Okamoto 1, Keiko Tazumi, Yasuaki Sanada, Mamiko Tsugane, Etsuko Uejima. Light-induced deterioration test of carboplatin under clinical settings. Yakugaku Zasshi. 2010 Oct;130(10):1369-74. doi: 10.1248/yakushi.130.1369.
33. Sari Nakagawa , Yoshie Toya, Yoshiaki Okamoto, Satoru Tsuneto, Sho Goya, Hitoshi Tanimukai, Yoichi Matsuda, Yumiko Ohno, Hiroshi Eto, Mamiko Tsugane, Tatsuya Takagi, Etsuko Uejima. Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives? J Palliat Med. 2010 May;13(5):535-40. doi: 10.1089/jpm.2009.0336.
34. Yoshiaki Okamoto , Satoru Tsuneto, Yoichi Matsuda, Takaya Inoue, Hitoshi Tanimukai, Keiko Tazumi, Yumiko Ono, Nobuo Kurokawa, Etsuko Uejima. A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients. J Pain Symptom Manage. 2007 Aug;34(2):217-22. doi: 10.1016/j.jpainsymman.2006.10.020. Epub 2007 Jun 4.
最近の著書
１．荒尾 晴恵，岡本 禎晃 がん緩和ケア薬 必携ガイドブック 南江堂 2024年3月
２．谷向 仁，岡本 禎晃 その精神症状どうします？初めの処方・次の処方 南江堂 2023年5月
３．細谷 美紀，里見 絵理子，岡本 禎晃 がん疼痛治療薬まるわりBOOK第2版 照林社 2023年9月
４．岡本 禎晃 緩和医療薬学 改訂第2版 南江堂 2023年4月
５．岡本 禎晃（分担執筆）．がん支持医療テキストブック サポーティブケアとサバイバーシップ 金原出版 2022年10月
６．岡本 禎晃（分担執筆）．臨床腫瘍薬学 第2版 じほう 2022年9月
７．岡本 禎晃（分担執筆）．終末期ケア上級専門士 公式テキスト
８．岡本 禎晃（分担執筆）．言語聴覚士のためのパーキンソン病のリハビリテーションガイド 協同医書出版社 2019年7月
９．岡本 禎晃，荒井 幸子編集．がん緩和ケアの薬の使い方 じほう 2019年6月
１０．恒藤 暁 岡本 禎晃．緩和ケアエッセンシャルドラッグ第4版 医学書院 2019年3月
主な社会・ 地域活動
日本ホスピス・緩和ケア研究振興財団 評議員 事業委員
担当科目
【看護学部】
臨床栄養学、臨床薬理学
【大学院】
臨床薬理学
【助産学専攻科】
周産期の基礎科学（薬理学・栄養学）
コメント
研究テーマも臨床の専門分野も緩和ケアです。